Caas Capital Management LP Candel Therapeutics, Inc. Put Options Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CADL
# of Institutions
22Shares Held
3.86MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC1.94MShares$11.3 Million8.58% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA812KShares$4.72 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA541KShares$3.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$848,0080.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX82.6KShares$480,7020.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $168M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...